These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2575224)

  • 1. Acute and long-term neurochemical effects of methylenedioxymethamphetamine in the rat.
    Schmidt CJ
    NIDA Res Monogr; 1989; 94():179-95. PubMed ID: 2575224
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans.
    Ricaurte GA
    NIDA Res Monogr; 1989; 94():306-22. PubMed ID: 2575227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
    Grob C; Bravo G; Walsh R
    Arch Gen Psychiatry; 1990 Mar; 47(3):288-9. PubMed ID: 1968330
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine.
    Zaczek R; Hurt S; Culp S; De Souza EB
    NIDA Res Monogr; 1989; 94():223-39. PubMed ID: 2575226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM
    Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of neurotoxicity after intra-raphe micro-injections of MDMA ("ecstasy").
    Paris JM; Cunningham KA
    NIDA Res Monogr; 1990; 105():333-4. PubMed ID: 1715034
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurochemical basis of neurotoxicity.
    Gibb JW; Johnson M; Hanson GR
    Neurotoxicology; 1990; 11(2):317-21. PubMed ID: 1978271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Ecstasy': a human neurotoxin?
    Peroutka SJ
    Arch Gen Psychiatry; 1989 Feb; 46(2):191. PubMed ID: 2563326
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies.
    De Souza EB; Battaglia G
    NIDA Res Monogr; 1989; 94():196-222. PubMed ID: 2575225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
    Hekmatpanah CR; McKenna DJ; Peroutka SJ
    Neurosci Lett; 1989 Sep; 104(1-2):178-82. PubMed ID: 2573011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New data intensify the agony over ecstasy.
    Barnes DM
    Science; 1988 Feb; 239(4842):864-6. PubMed ID: 2893452
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuropathological evaluation by combined immunohistochemistry and degeneration-specific methods: application to methylenedioxymethamphetamine.
    Scallet AC; Lipe GW; Ali SF; Holson RR; Frith CH; Slikker W
    Neurotoxicology; 1988; 9(3):529-37. PubMed ID: 2904668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amphetamine analogs on central nervous system neuropeptide systems.
    Hanson GR; Sonsalla P; Letter A; Merchant KM; Johnson M; Bush L; Gibb JW
    NIDA Res Monogr; 1989; 94():259-69. PubMed ID: 2481828
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of MDMA-like substances.
    Nichols DE; Oberlender R
    NIDA Res Monogr; 1989; 94():1-29. PubMed ID: 2575223
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    McKenna DJ; Peroutka SJ
    J Neurochem; 1990 Jan; 54(1):14-22. PubMed ID: 1967141
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    Eur J Pharmacol; 1987 Feb; 134(2):245-8. PubMed ID: 2883012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.
    Gollamudi R; Ali SF; Lipe G; Newport G; Webb P; Lopez M; Leakey JE; Kolta M; Slikker W
    Neurotoxicology; 1989; 10(3):455-66. PubMed ID: 2576302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.
    Davis WM; Hatoum HT; Waters IW
    Alcohol Drug Res; 1987; 7(3):123-34. PubMed ID: 2881551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.
    Schmidt CJ; Black CK; Taylor VL
    Eur J Pharmacol; 1990 May; 181(1-2):59-70. PubMed ID: 1974858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.